Biblio Discovery — Demo Discovery Service

15 results for "Mathur, Divya"

Showing 1–15 · 0.27 seconds · RSS

  1. Journal Article Full text

    A Transient Niche Regulates the Specification of Drosophila Intestinal Stem Cells

    Mathur, Divya; Bost, Alyssa; Driver, Ian et al.

    Science · 2010 · English · PubMed Central

    Stem cell niches are locations where stem cells reside and self-renew. Although studies have shown how niches maintain stem cell fate during tissue homeostasis, less is known about their roles in establishing stem cells. The adult Drosophila midgut is maintained by intestinal stem cells (ISCs)…

  2. Journal Article Full text

    Structural studies of phosphoglucose isomerase from Mycobacterium tuberculosis H37Rv

    Anand, Kanchan; Mathur, Divya; Anant, Avishek et al.

    Acta Crystallogr Sect F Struct Biol Cryst Commun · 2010 · English · PubMed Central

    Phosphoglucose isomerase (PGI) plays a key role in both glycolysis and gluconeogenesis inside the cell, whereas outside the cell it exhibits cytokine properties. PGI is also known to act as an autocrine motility factor, a neuroleukin agent and a differentiation and maturation mediator. Here, the…

  3. Journal Article Full text

    Greening up organic reactions with caffeine: applications, recent developments, and future directions

    Chaudhary, Ankita; Mathur, Divya; Gaba, Ritu et al.

    RSC Adv · 2024 · English · PubMed Central

    Numerous studies in the field of alkaloid chemistry have provided researchers with valuable insights into their unique properties as catalysts. Among the diverse natural catalysts, caffeine has emerged as a green, expedient, and biodegradable catalyst with high efficiency and applicability…

  4. Journal Article Full text

    Crystallization and preliminary X-ray characterization of phosphoglucose isomerase from Mycobacterium tuberculosis H37Rv

    Mathur, Divya; Anand, Kanchan; Mathur, Deepika et al.

    Acta Crystallogr Sect F Struct Biol Cryst Commun · 2007 · English · PubMed Central

    Phosphoglucose isomerase is a ubiquitous enzyme that catalyzes the isomerization of d-glucopyranose-6-phosphate to d-fructofuranose-6-phosphate. The present investigation reports the expression, purification, crystallization and preliminary crystallographic studies of the phosphoglucose isomerase…

  5. Journal Article Full text

    Analysis of the mouse embryonic stem cell regulatory networks obtained by ChIP-chip and ChIP-PET

    Mathur, Divya; Danford, Timothy W; Boyer, Laurie A et al.

    Genome Biol · 2008 · English · PubMed Central

    BACKGROUND: Genome-wide approaches have begun to reveal the transcriptional networks responsible for pluripotency in embryonic stem (ES) cells. Chromatin Immunoprecipitation (ChIP) followed either by hybridization to a microarray platform (ChIP-chip) or by DNA sequencing (ChIP-PET), has identified…

  6. Journal Article Full text

    Advances in chromone-based copper(ii) Schiff base complexes: synthesis, characterization, and versatile applications in pharmacology and biomimetic catalysis

    Kumar, Sumit; Arora, Aditi; Maikhuri, Vipin K. et al.

    RSC Adv · 2024 · English · PubMed Central

    Chromones are well known as fundamental structural elements found in numerous natural compounds and medicinal substances. The Schiff bases of chromones have a much wider range of pharmacological applications such as antitumor, antioxidant, anti-HIV, antifungal, anti-inflammatory, and antimicrobial…

  7. Journal Article Full text

    Integrated cytotoxicity screening and in silico analysis of coumarin nucleoside conjugates as computationally modeled VEGFR-2 inhibitors: oncocyte cytotoxicity, molecular docking, and dynamics simulation studies

    Mathur, Divya; Maikhuri, Vipin K.; Yadav, Sushma et al.

    In Silico Pharmacol · 2025 · English · PubMed Central

    The development of small-molecule tyrosine kinase inhibitors remains a high-priority strategy in modern oncology, particularly those targeting the Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) to disrupt pathological angiogenesis. This study utilized a dual-methodology approach to…

  8. Journal Article Full text

    Improving Discharge Rates to Home With the Help of Mobility Technicians: A Step in the Right Direction

    Patel, Swapnil V; Imburgio, Steven; Johal, Anmol S et al.

    Cureus · 2023 · English · PubMed Central

    Background Early ambulation during acute hospitalization has been associated with improved clinical outcomes for patients. Despite the benefits of mobility in the hospital setting, physical therapists and nursing staff are often constrained by time. Mobility technicians (MTs) are individuals with…

  9. Journal Article Full text

    Biocatalytic Synthesis of Novel Partial Esters of a Bioactive Dihydroxy 4-Methylcoumarin by Rhizopus oryzae Lipase (ROL)

    Kumar, Vinod; Mathur, Divya; Srivastava, Smriti et al.

    Molecules · 2016 · English · PubMed Central

    Highly regioselective acylation has been observed in 7,8-dihydroxy-4-methylcoumarin (DHMC) by the lipase from Rhizopus oryzae suspended in tetrahydrofuran (THF) at 45 °C using six different acid anhydrides as acylating agents. The acylation occurred regioselectively at one of the two hydroxy groups…

  10. Journal Article Full text

    Improving Patient Outcomes Using Measures to Increase Discharge Rates to Home

    Patel, Swapnil V; Arcidiacono, Anne; Austin, Christopher P et al.

    Cureus · 2024 · English · PubMed Central

    Background Post-acute care (PAC) centers are facilities used for recuperation, rehabilitation, and symptom management in an effort to improve the long-term outcomes of patients. PAC centers include skilled nursing facilities, inpatient rehabilitation facilities, and long-term care hospitals. In the…

  11. Journal Article Full text

    Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4

    Lyssiotis, Costas A.; Foreman, Ruth K.; Staerk, Judith et al.

    Proc Natl Acad Sci U S A · 2009 · English · PubMed Central

    Ectopic expression of defined transcription factors can reprogram somatic cells to induced pluripotent stem (iPS) cells, but the utility of iPS cells is hampered by the use of viral delivery systems. Small molecules offer an alternative to replace virally transduced transcription factors with…

  12. Journal Article Full text

    Preclinical Evaluation of (89)Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy

    Maresca, Kevin P.; Chen, Jianqing; Mathur, Divya et al.

    Mol Imaging Biol · 2021 · English · PubMed Central

    PURPOSE: A sensitive and specific imaging biomarker to monitor immune activation and quantify pharmacodynamic responses would be useful for development of immunomodulating anti-cancer agents. PF-07062119 is a T cell engaging bispecific antibody that binds to CD3 and guanylyl cyclase C, a protein…

  13. Journal Article Full text

    Anti-Extra Domain B Splice Variant of Fibronectin Antibody–Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade

    Hooper, Andrea T.; Marquette, Kimberly; Chang, Chao-Pei Betty et al.

    Mol Cancer Ther · 2022 · English · PubMed Central

    Extra domain B splice variant of fibronectin (EDB+FN) is an extracellular matrix protein (ECM) deposited by tumor-associated fibroblasts, and is associated with tumor growth, angiogenesis, and invasion. We hypothesized that EDB+FN is a safe and abundant target for therapeutic intervention with an…

  14. Journal Article Full text

    A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies

    Abayasiriwardana, Keith; Wu, Lei; Laklai, Hanane et al.

    Mol Cancer Ther · 2025 · English · PubMed Central

    Immune checkpoint inhibitors have shown limited success in breast cancer, the most common and deadly cancer in women worldwide. Novel immune therapies, such as CD3-engaging bispecific antibodies, have shown clinical promise in hematologic malignancies. However, developing CD3 bispecifics for solid…

  15. Journal Article Full text

    Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors

    Root, Adam R.; Guntas, Gurkan; Katragadda, Madan et al.

    MAbs · 2021 · English · PubMed Central

    We report here the discovery and optimization of a novel T cell retargeting anti-GUCY2C x anti-CD3ε bispecific antibody for the treatment of solid tumors. Using a combination of hybridoma, phage display and rational design protein engineering, we have developed a fully humanized and manufacturable…